These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 11932410)

  • 21. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
    Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
    J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells
    Mastrodomenico V; LoMascolo NJ; Firpo MR; Villanueva Guzman MDM; Zaporowski A; Mounce BC
    mSphere; 2023 Jun; 8(3):e0003623. PubMed ID: 37097178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
    Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
    Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of translational initiation in coxsackievirus B3 suggests an alternative explanation for the high frequency of R+4 in the eukaryotic consensus motif.
    Harkins S; Cornell CT; Whitton JL
    J Virol; 2005 Jan; 79(2):987-96. PubMed ID: 15613327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coxsackievirus B3 replication and pathogenesis.
    Garmaroudi FS; Marchant D; Hendry R; Luo H; Yang D; Ye X; Shi J; McManus BM
    Future Microbiol; 2015; 10(4):629-53. PubMed ID: 25865198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
    Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
    Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.
    Luo H; Zhang J; Dastvan F; Yanagawa B; Reidy MA; Zhang HM; Yang D; Wilson JE; McManus BM
    J Virol; 2003 Jan; 77(1):1-9. PubMed ID: 12477805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice.
    Yanagawa B; Spiller OB; Choy J; Luo H; Cheung P; Zhang HM; Goodfellow IG; Evans DJ; Suarez A; Yang D; McManus BM
    Lab Invest; 2003 Jan; 83(1):75-85. PubMed ID: 12533688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
    Smithee S; Tracy S; Chapman NM
    J Virol; 2015 Dec; 89(23):11761-72. PubMed ID: 26355088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholic Acid Attenuates ER Stress-Induced Cell Death in Coxsackievirus-B3 Infection.
    Han JY; Jeong HI; Park CW; Yoon J; Ko J; Nam SJ; Lim BK
    J Microbiol Biotechnol; 2018 Jan; 28(1):109-114. PubMed ID: 29032641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
    Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region.
    Wang L; Qin Y; Tong L; Wu S; Wang Q; Jiao Q; Guo Z; Lin L; Wang R; Zhao W; Zhong Z
    Antiviral Res; 2012 Feb; 93(2):270-279. PubMed ID: 22197249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells.
    Luan Y; Dai HL; Yang D; Zhu L; Gao TL; Shao HJ; Peng X; Jin ZF
    Virus Res; 2012 Jan; 163(1):183-9. PubMed ID: 21945637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis.
    Klump WM; Bergmann I; Müller BC; Ameis D; Kandolf R
    J Virol; 1990 Apr; 64(4):1573-83. PubMed ID: 2157045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication and persistence of coxsackieviruses B3 in human fibroblasts.
    Tonew M; Hartmann M; Schmidtke M; Stelzner A
    Zentralbl Bakteriol; 1995 Jan; 282(1):92-101. PubMed ID: 7734835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
    Luo H; Yanagawa B; Zhang J; Luo Z; Zhang M; Esfandiarei M; Carthy C; Wilson JE; Yang D; McManus BM
    J Virol; 2002 Apr; 76(7):3365-73. PubMed ID: 11884562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.